AssetMark’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
AssetMark's MRNA Position: Q3 2026 in Review
AssetMark increased its Moderna (MRNA) stake by 14% in Q3 2026, buying an estimated $12.3K and bringing the position to 912 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1505.
AssetMark first reported a position in MRNA in Q2 2021 and has held it in 22 quarters since. The position peaked at $73.3M in Q1 2023. 877 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- AssetMark held 912 shares of Moderna worth $176K as of Q3 2026.
- AssetMark bought 114 Moderna shares in Q3 2026, an estimated $12.3K.
- Moderna made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1505 holding.
- AssetMark first reported a position in Moderna in Q2 2021 and has held it in 22 quarters since.
- AssetMark's Moderna position peaked at $73.3M in Q1 2023.
- 877 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.